Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9/CD82 and suppresses the Wnt/β-catenin signal via ISGylation of β-catenin

Gut

Volumn 59, Issue 7, 2010, Pages 907-917

  Lee, Ji Hee ^a   Bae, Jeong A ^a   Lee, Jae Hyuk ^b   Seo, Young Woo ^c   Kho, Dhong Hyo ^a   Sun, Eun Gene ^a   Lee, Song Eun ^a   Cho, Sang Hee ^b   Joo, Young Eun ^b   Ahn, Kyu Youn ^a   Chung, Ik Joo ^b   Kim, Kyung Keun ^a  

^a Brain Korea 21 Project   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CD82 ANTIGEN; CD9 ANTIGEN; GALECTIN; GANGLIOSIDE; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOPROTEIN; GLYCOPROTEIN 90K; LACTOSE; PROTEASOME; TRISIALOTETRAHEXOSYLGANGLIOSIDE; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; COLON; COLORECTAL CANCER; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR GROWTH; TUMOR MODEL; UBIQUITINATION;

ANIMALS; ANTIGENS, CD; BETA CATENIN; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GALECTINS; GLYCOPROTEINS; HUMANS; KANGAI-1 PROTEIN; LACTOSE; LIVER NEOPLASMS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UBIQUITIN; UBIQUITINS; WNT PROTEINS;

EID: 77953993631     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.194068     Document Type: Article

References (31)

1. Iacobelli S, Arno E, D'Orazio A, et al. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 1986;46:3005-10. (Pubitemid 16074320)
2. Ullrich A, Sures I, D'Egidio M, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 1994;269:18401-7.
3. Grassadonia A, Tinari N, Iurisci I, et al. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 2004;19:551-6.
4. Powell TJ, Schreck R, McCall M, et al. A tumor-derived protein which provides T-cell costimulation through accessory cell activation. J Immunother Emphasis Tumor Immunol 1995;17:209-21.
5. Jallal B, Powell J, Zachwieja J, et al. Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res 1995;55:3223-7.
6. Iacobelli S, Sismondi P, Giai M, et al. Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer 1994;69:172-6. (Pubitemid 24021843)
7. Marchetti A, Tinari N, Buttitta F, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002;62:2535-9.
8. Lahm H, André S, Hoeflich A, et al. Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J 2004;20:227-38.
9. Lee JH, Park SR, Chay KO, et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 2004;64:4235-43.
10. Lee JH, Cho ES, Kim MY, et al. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res 2005;65:8993-9003.
11. Kho DH, Bae JA, Lee JH, et al. KITENIN recruits Dishevelled/PKCδ to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 2009;58:509-19.
12. Ulmer TA, Keeler V, Loh L, et al. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. J Cell Biochem 2006;98:1351-66.
13. Shimura T, Takenaka Y, Fukumori T, et al. Implication of galectin-3 in Wnt signaling. Cancer Res 2005;65:3535-7.
14. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7.
15. Liu J, Stevens J, Rote CA, et al. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001;7:927-36.
16. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 2001;7:915-26.
17. Farrell PJ, Broeze RJ, Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 1979;279:523-5. (Pubitemid 9195259)
18. Dastur A, Beaudenon S, Kelley M, et al. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006;28:4334-8.
19. Zou W, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 2006;281:3989-94.
20. Todeschini AR, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 2008;1780:421-33.
21. Huang CL, Liu D, Masuya D, et al. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 2004;23:7475-83.
22. Rubinstein E, Le Naour F, Lagaudrière-Gesbert C, et al. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996;26:2657-65.
23. Ono M, Handa K, Sonnino S, et al. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 2001;40:6414-21.
24. Brabletz T, Hlubek F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005;179:56-65.
25. Ritchie KJ, Zhang DE. ISG15: the immunological kin of ubiquitin. Semin Cell Dev Biol 2004;15:237-46.
26. Yuan W, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 2001;20:362-71.
27. Iacobelli S, Scambia G, Natoli C, et al. Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells. Int J Cancer 1988;42:182-4.
28. Natoli C, Garufi C, Tinari N, et al. Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease. Br J Cancer 1993;67:564-7. (Pubitemid 23077653)
29. Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009;9:40-55.
30. Friedman J, Trahey M, Weissman I. Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C. Proc Natl Acad Sci USA 1993;90:6815-19.
31. Yu B, Wright SD. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14. J Inflamm 1995;45:115-25.